4
Changes in Ownership
Protagonist Therapeutics, Inc Filed Acc 0001209191-17-050652
Chief Scientific Officer sold 3,500 shares at $15.00 ($52,500)
- Chief Scientific Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Liu David Y · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-28 | Exercise or conversion : show line 1 in the form | +3,500 | $4.21 | $14,735 | 5,500 | D |
| 2017-08-28 | Sale : show line 2 in the form | −3,500 | $15.00 | $52,500 | 2,000 | D |
| Open-market sales · 3,500 sh · avg $15.00 · $52,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-08-28 | Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) | −3,500 | 42,331 | D |
Loading xslF345X03/doc4.xml…